AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11204938 — intervention group
Group type: EXPERIMENTAL
Intervention: Novofem (1 mg estradiol + 1 mg norethisterone acetate)
Number of subjects: 23
Study 11204938 — intervention group
Group type: COMPARATOR
Intervention: Activelle (1 mg estradiol + 0.5 mg norethisterone acetate)
Number of subjects: 23
Study 9603128 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐wk supervised, multimodality endurance exercise training program (EXT)
Number of subjects: 20
Study 7530064 — intervention group
Group type: EXPERIMENTAL
Intervention: N,G‐nitro‐L‐arginine methyl ester (L‐NAME)
Number of subjects: 6
Study 7530064 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 6
Study 3134898 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold sodium thiomalate
Number of subjects: 0
Study 3134898 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin
Number of subjects: 0
Study 3134898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31126277 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex on-site intervention including physician visits, nursing staff involvement, computerized documentation system (CoCare Cockpit), joint trainings and audits, structured treatment paths, after-hours medical care availability.
Number of subjects: 4000
Study 31126277 — intervention group
Group type: COMPARATOR
Intervention: Care/treatment as usual (control group).
Number of subjects: 4000
Study 28926793 — intervention group
Group type: EXPERIMENTAL
Intervention: CX157
Number of subjects: 0
Study 28926793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24918474 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise (NSE)
Number of subjects: 216
Study 24918474 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise with behavioral approach
Number of subjects: 216
Study 24918474 — intervention group
Group type: COMPARATOR
Intervention: Prescription of Physical Activity (PPA)
Number of subjects: 216
Study 24918474 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise without behavioral approach
Number of subjects: 216
Study 23743809 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment with indapamide sustained release 1.5 mg +/- perindopril 2-4 mg
Number of subjects: 263
Study 23743809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study 23743809 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 263
Study 21649813 — intervention group
Group type: EXPERIMENTAL
Intervention: HA(E) (Emervel Deep)
Number of subjects: 0
Study 21649813 — intervention group
Group type: COMPARATOR
Intervention: HA(P) (Restylane Perlane)
Number of subjects: 0
Study 18319586 — intervention group
Group type: EXPERIMENTAL
Intervention: HFA-BDP 400 microg b.i.d., salmeterol 50 microg b.i.d. and oxitropium bromide 200 microg t.i.d.
Number of subjects: 8
Study 18319586 — intervention group
Group type: COMPARATOR
Intervention: Placebo, salmeterol 50 microg b.i.d. and oxitropium bromide 200 microg t.i.d.
Number of subjects: 8
Study 16507602 — intervention group
Group type: EXPERIMENTAL
Intervention: 41% leucine (41% Leu) EAA
Number of subjects: 4
Study 16507602 — intervention group
Group type: COMPARATOR
Intervention: 26% leucine (26% Leu) EAA
Number of subjects: 4
Study 12656812 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion alone every 2 weeks (group 1)
Number of subjects: 20
Study 12656812 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion with 15% trichloroacetic acid (TCA) every 3 weeks (group 2)
Number of subjects: 20
Study 10730285 — intervention group
Group type: EXPERIMENTAL
Intervention: Compoglass-F/Syntac SC with salivary contamination
Number of subjects: 16
Study 10730285 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyract-AP/Prime and Bond 2.1 with salivary contamination
Number of subjects: 16
Study 10730285 — intervention group
Group type: COMPARATOR
Intervention: Compoglass-F/Syntac SC without salivary contamination
Number of subjects: 16
Study 10730285 — intervention group
Group type: COMPARATOR
Intervention: Dyract-AP/Prime and Bond 2.1 without salivary contamination
Number of subjects: 16
Study 9186346 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized nuclear texture analysis
Number of subjects: 262
Study 9186346 — intervention group
Group type: EXPERIMENTAL
Intervention: Sialyl Lewis(x) molecules
Number of subjects: 262
Study 9186346 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine clinical and laboratory data (sedimentation rate, alkaline phosphatase, hemoglobin)
Number of subjects: 262
Study 9186346 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance status, pain due to metastasis, extent of bone lesions
Number of subjects: 262
Study 7903213 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertatolol 5 mg once daily
Number of subjects: 40
Study 7903213 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol 200 mg once daily
Number of subjects: 40
Study 6741666 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive group therapy
Number of subjects: 28
Study 6741666 — intervention group
Group type: EXPERIMENTAL
Intervention: Covert sensitization
Number of subjects: 28
Study 6741666 — intervention group
Group type: COMPARATOR
Intervention: Non-specific control
Number of subjects: 28
Study 6741666 — intervention group
Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 28
Study 31064260 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning classification using LASSO approach
Number of subjects: 483
Study 31064260 — intervention group
Group type: EXPERIMENTAL
Intervention: Background data including teacher and caregiver ratings
Number of subjects: 483
Study 29223479 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab plus trastuzumab with anthracycline-containing chemotherapy (FEC)
Number of subjects: 223
Study 29223479 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab plus trastuzumab with anthracycline-free chemotherapy (docetaxel)
Number of subjects: 223
Study 29223479 — intervention group
Group type: COMPARATOR
Intervention: Pertuzumab plus trastuzumab with docetaxel and carboplatin
Number of subjects: 223
Study 27177615 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorella (5 g/d)
Number of subjects: 34
Study 27177615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 22643187 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompressive surgery with additional implantation of the Coflex interspinous device
Number of subjects: 62
Study 22643187 — intervention group
Group type: COMPARATOR
Intervention: Decompressive surgery alone
Number of subjects: 62
Study 21031523 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 molar gadobenate dimeglumine
Number of subjects: 74
Study 21031523 — intervention group
Group type: COMPARATOR
Intervention: 1.0 molar gadobutrol
Number of subjects: 74
Study 16435071 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (well-informed about statins)
Number of subjects: 202
Study 16435071 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (not well-informed about statins)
Number of subjects: 202
Study 11465710 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac + Misoprostol (75 mg diclofenac + 200 microg misoprostol twice daily for 6 weeks)
Number of subjects: 227
Study 11465710 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (1,000 mg acetaminophen 4 times daily for 6 weeks)
Number of subjects: 227
Study 9711370 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive case management
Number of subjects: 73
Study 9711370 — intervention group
Group type: COMPARATOR
Intervention: Routine case management
Number of subjects: 73
Study 7986543 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonicated albumin with 50% dextrose (threefold dilution, sonicated for 80 to 100 seconds)
Number of subjects: 10
Study 7986543 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonicated albumin with 50% dextrose (sevenfold dilution, sonicated for 80 to 100 seconds)
Number of subjects: 10
Study 7986543 — intervention group
Group type: COMPARATOR
Intervention: Sonicated albumin (control)
Number of subjects: 10
Study 7986543 — intervention group
Group type: COMPARATOR
Intervention: Sonicated albumin with 50% dextrose (onefold dilution, sonicated for 40 seconds)
Number of subjects: 10
Study 7986543 — intervention group
Group type: COMPARATOR
Intervention: Sonicated albumin with 50% dextrose (threefold dilution, sonicated for 40 seconds)
Number of subjects: 10
Study 7986543 — intervention group
Group type: COMPARATOR
Intervention: Sonicated albumin with 50% dextrose (sevenfold dilution, sonicated for 40 seconds)
Number of subjects: 10
Study 2543201 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilevalol 200 mg
Number of subjects: 178
Study 2543201 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 20 mg
Number of subjects: 178
Study 4853634 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training (indoors, three sessions a week, individual training) for 3 months
Number of subjects: 63
Study 4853634 — intervention group
Group type: COMPARATOR
Intervention: Reference group (29 patients)
Number of subjects: 63
Study 31607603 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose oral Rotarix vaccine
Number of subjects: 220
Study 31607603 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose oral Rotarix vaccine
Number of subjects: 220
Study 30076113 — intervention group
Group type: EXPERIMENTAL
Intervention: IV rt-PA treatment for patients with body weight >100 kg
Number of subjects: 105
Study 26437613 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile tea (3 g/150 mL hot water) 3 times per day immediately after meals for 8 weeks
Number of subjects: 64
Study 26437613 — intervention group
Group type: COMPARATOR
Intervention: Water regimen for 8 weeks
Number of subjects: 64
Study 24700386 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 360 mg
Number of subjects: 60
Study 24700386 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 240 mg
Number of subjects: 60
Study 24700386 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg
Number of subjects: 60
Study 24700386 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg
Number of subjects: 60
Study 22587684 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counselling
Number of subjects: 625
Study 22587684 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face counselling
Number of subjects: 625
Study 22587684 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 625
Study 20346304 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline heart rate (HR) >= 70 beats/min
Number of subjects: 9580
Study 20346304 — intervention group
Group type: COMPARATOR
Intervention: Baseline heart rate (HR) < 70 beats/min
Number of subjects: 9580
Study 20346304 — intervention group
Group type: EXPERIMENTAL
Intervention: Every 10-beats/min increase in HR at rest
Number of subjects: 9580
Study 20346304 — intervention group
Group type: EXPERIMENTAL
Intervention: HR >= 70 beats/min
Number of subjects: 9580
Study 19073842 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 48
Study 19073842 — intervention group
Group type: COMPARATOR
Intervention: Sodium Valproate
Number of subjects: 48
Study 16416508 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-imposed restrictions on driving conditions
Number of subjects: 579
Study 16416508 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-imposed consequences for driving rule violations
Number of subjects: 579
Study 16416508 — intervention group
Group type: EXPERIMENTAL
Intervention: Female parents
Number of subjects: 579
Study 16416508 — intervention group
Group type: EXPERIMENTAL
Intervention: Male teens
Number of subjects: 579
Study 16416508 — intervention group
Group type: EXPERIMENTAL
Intervention: Discordance with restricted driving conditions
Number of subjects: 579
Study 12885715 — intervention group
Group type: EXPERIMENTAL
Intervention: LCP-supplemented formula (LF)
Number of subjects: 397
Study 12885715 — intervention group
Group type: COMPARATOR
Intervention: Control-formula (CF)
Number of subjects: 397
Study 12885715 — intervention group
Group type: COMPARATOR
Intervention: Breastfed (BF)
Number of subjects: 397
Study 10095142 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk feeding
Number of subjects: 18
Study 8971950 — intervention group
Group type: EXPERIMENTAL
Intervention: New lower-prime hollow-fibre membrane oxygenators with uncoated stainless steel heat exchangers
Number of subjects: 60
Study 8971950 — intervention group
Group type: COMPARATOR
Intervention: Control group (other models of membrane oxygenators)
Number of subjects: 60
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty
Number of subjects: 826
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesion stenosis 60% to 74%
Number of subjects: 826
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesion stenosis 75% to 89%
Number of subjects: 826
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesion stenosis 90% to 99%
Number of subjects: 826
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesion stenosis 100%
Number of subjects: 826
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncalcified lesions
Number of subjects: 826
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcified lesions
Number of subjects: 826
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonthrombotic lesions
Number of subjects: 826
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombotic lesions
Number of subjects: 826
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Other vessels
Number of subjects: 826
Study 1987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Right coronary artery lesions
Number of subjects: 826
Study 6881497 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 15
Study 6881497 — intervention group
Group type: COMPARATOR
Intervention: General anaesthetic
Number of subjects: 15
Study 6881497 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 15
Study 31190621 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0
Study 31190621 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 0
Study 29460884 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged plaster of Contractubex
Number of subjects: 109
Study 29460884 — intervention group
Group type: COMPARATOR
Intervention: Dynamic observation (Control)
Number of subjects: 109
Study 27587419 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver-impregnated dressings
Number of subjects: 117
Study 27587419 — intervention group
Group type: COMPARATOR
Intervention: Standard dressings
Number of subjects: 117
Study 24508468 — intervention group
Group type: EXPERIMENTAL
Intervention: COPA model (integrated primary care with intensive case management)
Number of subjects: 428
Study 24508468 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 428
Study 21423055 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3FA supplements (stopped an average of 2.3 days before surgery)
Number of subjects: 95
Study 21423055 — intervention group
Group type: COMPARATOR
Intervention: Control group (no n‐3FA supplements)
Number of subjects: 95
Study 21423055 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95
Study 21423055 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3FA supplements
Number of subjects: 95
Study 20946445 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone advice (n=235) in addition to usual care
Number of subjects: 468
Study 20946445 — intervention group
Group type: COMPARATOR
Intervention: Usual care only (n=233)
Number of subjects: 468
Study 16971011 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta‐brachytherapy (Beta‐Cath)
Number of subjects: 37
Study 16971011 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel‐eluting stent implantation (Taxus‐Express2)
Number of subjects: 37
Study 16971011 — intervention group
Group type: COMPARATOR
Intervention: Stent implantation (Taxus‐Express2)
Number of subjects: 37
Study 15747149 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D ultrasound (3D US)
Number of subjects: 60
Study 15747149 — intervention group
Group type: COMPARATOR
Intervention: 2D ultrasound (2D US)
Number of subjects: 60
Study 15747149 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2D and 3D ultrasound
Number of subjects: 60
Study 12174841 — intervention group
Group type: EXPERIMENTAL
Intervention: Erbium:yttrium-aluminum-garnet laser with energy level of 250 mJ at 103 pulses per second
Number of subjects: 0
Study 12174841 — intervention group
Group type: EXPERIMENTAL
Intervention: Erbium:yttrium-aluminum-garnet laser with energy level of 80 mJ at 166 pulses per second
Number of subjects: 0
Study 12174841 — intervention group
Group type: EXPERIMENTAL
Intervention: Erbium:yttrium-aluminum-garnet laser with energy level of 80 mJ at 166 pulses per second with concomitant water irrigation
Number of subjects: 0
Study 10467204 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ST monitoring
Number of subjects: 206
Study 8684301 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-occupational (domestic and environmental) exposure to asbestos
Number of subjects: 0
Study 8684301 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to MMMF and other agents
Number of subjects: 0
Study 1977731 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 12
Study 1977731 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 12
Study 1977731 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 12
Study 1977731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 361068 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg twice daily) for 4 to 17 weeks
Number of subjects: 33
Study 361068 — intervention group
Group type: COMPARATOR
Intervention: Placebo (one tablet twice daily) for 4 to 12 weeks
Number of subjects: 33
Study 31390590 — intervention group
Group type: EXPERIMENTAL
Intervention: TES program (screening and stepped care)
Number of subjects: 349
Study 31390590 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 349
Study 28478317 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum sealing drainage (group A)
Number of subjects: 80
Study 28478317 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (group B)
Number of subjects: 80
Study 25311059 — intervention group
Group type: EXPERIMENTAL
Intervention: High nut consumption (≥1 time/day)
Number of subjects: 9660
Study 24280469 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Spinal Orthopedic Manipulation (TCSOM)
Number of subjects: 60
Study 24280469 — intervention group
Group type: COMPARATOR
Intervention: Pinaverium Bromide Dicetel (PBD)
Number of subjects: 60
Study 21676131 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective Story Task
Number of subjects: 35
Study 21676131 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 35
Study 20214051 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5%/dorzolamide 20%/brimonidine 0.2%
Number of subjects: 0
Study 20214051 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5%/dorzolamide 2%
Number of subjects: 0
Study 16960270 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 cm H2O of CPAP during cardiopulmonary bypass (Group I; n = 60)
Number of subjects: 120
Study 16960270 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group II; n = 60) where the patient's lungs were vented to atmosphere during the bypass period
Number of subjects: 120
Study 15074084 — intervention group
Group type: EXPERIMENTAL
Intervention: Yangxue Qingnao granule (YXQN) plus conventional medical treatment
Number of subjects: 167
Study 15074084 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical treatment alone
Number of subjects: 167
Study 11140187 — intervention group
Group type: EXPERIMENTAL
Intervention: Training to shift attention between acoustic cues; feedback based on category-level identification; duration not specified.
Number of subjects: 0
Study 9022575 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic MR imaging
Number of subjects: 40
Study 9022575 — intervention group
Group type: COMPARATOR
Intervention: T2-weighted images
Number of subjects: 40
Study 9022575 — intervention group
Group type: COMPARATOR
Intervention: Contrast-enhanced T1-weighted images
Number of subjects: 40
Study 8198932 — intervention group
Group type: EXPERIMENTAL
Intervention: [S]-leucovorin (300 mg m-2)
Number of subjects: 21
Study 8198932 — intervention group
Group type: COMPARATOR
Intervention: rac-leucovorin (600 mg m-2)
Number of subjects: 21
Study 2822879 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg atenolol daily
Number of subjects: 26
Study 2822879 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg enalapril daily
Number of subjects: 26
Study 2822879 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg atenolol and 10 mg enalapril (low-dose combination)
Number of subjects: 26
Study 2822879 — intervention group
Group type: COMPARATOR
Intervention: Placebo (during 2-week placebo period)
Number of subjects: 26
Study 2822879 — intervention group
Group type: COMPARATOR
Intervention: Atenolol vs Enalapril
Number of subjects: 26
Study 29299736 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 15
Study 29299736 — intervention group
Group type: COMPARATOR
Intervention: Control group (no probiotic supplementation)
Number of subjects: 15
Study 29862395 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement based on Lippia citriodora and Hibiscus sabdariffa polyphenolic extracts
Number of subjects: 54
Study 29862395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 26257041 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper airway stimulation (UAS) system implantation, first implant (n=22)
Number of subjects: 126
Study 26257041 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper airway stimulation (UAS) system implantation, fifth implant (n=10)
Number of subjects: 126
Study 26257041 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper airway stimulation (UAS) system implantation
Number of subjects: 126
Study 24184147 — intervention group
Group type: COMPARATOR
Intervention: Sublingual immunotherapy (SLIT) in adults (n=54)
Number of subjects: 153